The authorisation provisions should ensure the good functioning of the internal market
while assuring that the risks from substances of very high concern are properly controlled.
Authorisations for the placing on the market and use should be granted by the Commission
only if the risks arising from their use are adequately controlled, where this is possible, or
the use can be justified for socio-economic reasons and no suitable alternatives are
available, which are economically and technically viable.
(23) The restriction provisions should allow the manufacturing, placing on the market and use
of substances presenting risks that need to be addressed, to be made subject to total or
partial bans or other restrictions, based on an assessment of those risks.
(24) In preparation for this Regulation, the Commission has launched REACH Implementation
Projects (RIPs), involving relevant experts from stakeholder groups. Some of those
projects aim at developing draft guidelines and tools which should help the Commission,
the Agency, Member States, manufacturers, importers and downstream users of substances
to fulfil, in concrete terms, their obligations under this Regulation. This work should
enable the Commission and the Agency to make available appropriate technical guidance,
in due time, with regard to the deadlines introduced by this Regulation.